Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ELISA assay for melarsoprol.

L Maes1, F Doua, R Hamers

  • 1Instituut voor Moleculaire Biologie, Vrije Universiteit Brussel, Belgique.

Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales
|January 1, 1988
PubMed
Summary

A new ELISA test accurately measures melarsoprol, a crucial drug for treating sleeping sickness, in patient samples. This method aids in optimizing treatment and reducing severe side effects like encephalopathy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From microstructure to mechanics: A multi-constituent micro-scale computational model of arterial tissue.

Computers in biology and medicine·2025
Same author

Developmental venous anomalies: benign in nature, potentially debilitating for life.

Acta neurologica Belgica·2025
Same author

Antileishmanial Aminopyrazoles: Studies into Mechanisms and Stability of Experimental Drug Resistance.

Antimicrobial agents and chemotherapy·2020
Same author

Transmission potential of paromomycin-resistant Leishmania infantum and Leishmania donovani.

The Journal of antimicrobial chemotherapy·2019
Same author

Need for sustainable approaches in antileishmanial drug discovery.

Parasitology research·2019
Same author

Immunosuppression of Syrian golden hamsters accelerates relapse but not the emergence of resistance in Leishmania infantum following recurrent miltefosine pressure.

International journal for parasitology. Drugs and drug resistance·2018

Area of Science:

  • Biochemistry
  • Pharmacology
  • Clinical Diagnostics

Background:

  • Melarsoprol is a critical drug for treating human African trypanosomiasis.
  • Accurate quantification of melarsoprol in biological fluids is essential for therapeutic drug monitoring.
  • Current methods may lack the sensitivity required for precise pharmacokinetic studies.

Purpose of the Study:

  • To develop and validate a sensitive enzyme-linked immunosorbent assay (ELISA) for melarsoprol.
  • To enable the detection of melarsoprol in human serum and cerebrospinal fluid (CSF) at the nanogram per milliliter level.
  • To facilitate pharmacokinetic and metabolic studies for improved melarsoprol treatment.

Main Methods:

  • Development of a highly sensitive enzyme-linked immunosorbent assay (ELISA).
  • Validation of the ELISA for detecting melarsoprol in human serum and cerebrospinal fluid.
  • Preliminary analysis of patient samples to confirm assay feasibility.

Main Results:

  • The developed ELISA method demonstrates high sensitivity, detecting melarsoprol at the ng/ml level.
  • Preliminary analyses confirmed the feasibility of using the assay in patient serum and CSF.
  • The method is suitable for quantifying melarsoprol in complex biological matrices.

Conclusions:

  • A sensitive and feasible ELISA method for melarsoprol quantification in human serum and CSF has been established.
  • This assay is crucial for conducting essential pharmacokinetic and metabolic studies.
  • Improved drug monitoring via this assay may lead to optimized treatment regimens and reduced adverse effects, including lethal encephalopathies.

Related Experiment Videos